Enhancement of photodynamic therapy by use of aminolevulinic acid/glycolic acid drug mixture

Journal of Experimental Therapeutics and Oncology

Volumn 4, Issue 2, 2004, Pages 121-129

  Ziolkowski, Piotr ^a   Osiecka, Beata J ^a   Oremek, Gerhard ^b   Siewinski, Maciej ^a   Symonowicz, Krzysztof ^a   Saleh, Yousif ^a   Bronowicz, Andrzej ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

5 aminolevulinic acid; Human squamous cell carcinoma; In vitro in vivo studies; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; DIMETHYL SULFOXIDE; EDETIC ACID; GLYCOLIC ACID; LANOLIN ALCOHOL; PORPHYRIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOMA CELL; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MIXTURE; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; INCUBATION TIME; MALE; MOUSE; NONHUMAN; OINTMENT; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN PENETRATION; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; TUMOR REGRESSION;

ADENOCARCINOMA; ADMINISTRATION, CUTANEOUS; AGED; AMINOLEVULINIC ACID; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; COLONIC NEOPLASMS; DIMETHYL SULFOXIDE; EDETIC ACID; FEMALE; FIBROBLASTS; GLYCOLATES; HUMANS; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 4043101830     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kennedy JC, RH Pettier, DC Pross. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J.Photochem. Photobiol. B:Biol. 6: 143-148, 1990
2. Bolsen K, K Lang, B Verwohlt, C Fritsch, G Goerz. In vitro induction of porphyrin biosynthesis in various human cells after incubation with 5-aminolevulinic acid. Arch.Dermatol.Res. 288: 32OA, 1996.
3. Malik Z, H Lugaci. Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. Br.J. Cancer 56: 589-595, 1987.
4. Fritsch C, G Goerz, T Ruzicka. Photodynamic therapy in dermatology. A review. Arch.Dermatol 134: 207-214, 1998.
5. Fritsch C, J Batz, K Bolsen, Schulte KW, Zumdick M., Ruzicka T, Goerz G. Ex vivo application of 5-aminolevulinic acid induced high and specific porphyrin levels in human skin tumors: possible basis for selective photodynamic therapy. Photochem.Photobiol 66: 114-118, 1997.
6. Calzavara-Pinton PG. Repetitive photodynamic therapy with topical 5-aminolevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumors. J.Photochem.Photobiol.B:Biol 29: 53-57, 1995.
7. Lang K, K Bolsen, W Stahl, Ruzicka T, Sies H, Lehmann P, Fritsch C. The 5-aminolevulinic acid-induced porphyrin biosynthesis in benign and malignant cells of the skin. J.Photochem.Photobiol.B:Biol 65: 29-34, 2001.
8. Lowry OH, NJ Rosebrough, AL. Farr, RJ Randall. Protein measurement with the Folin phenol reagent. Biol.Chem 193: 265, 1951.
9. Jeffes EWB. Levulan®: the first approved topical photosensitizer for the treatment of actinic keratosis. J.Dermatol.Treat 13: 19-23, 2002.
10. Barry BW. Dermatological formulation: percutaneous absorption, drugs and pharmaceutical sciences. New York, Marcel Dekker, 18, 1983.
11. Juzeniene A, P Juzenas, V Iani, J Moan. Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model. Photochem.Photobiol 76: 329-334, 2002.
12. Curnow A, BW McIlroy, MJ Postle-Hacon, JB Porter, AJ MacRobert, SG Bown. Enhancement of 5-aminolevulinic acid-induced photodynamic therapy in normal rat colon using hydroxypyridinone iron-chelating agents. Br.J.Cancer, 78: 1278-1282, 1998.
13. Tsai JC, IH Chen, TW Wong, YL Lo. In vitro/in vivo correlations between transdermal delivery of 5-aminolevulinic acid and cutaneous protoporphyrin IX accumulation and effect of formulation. Br.J.Dermatol 146: 853-862, 2002.
14. Juzeniene A, P Juzenas, O Kaalhus, V Iani, J Moan. Temperature effect on accumulation of protoporphyrin IX after topical application of 5-aminolevulinic acid and its methylester and hexylester derivatives in normal mouse skin. Photochem.Photobiol 76: 452-456, 2002.
15. Markham T, P Collins. Topical 5-aminolevulinic acid photodynamic therapy for extensive scalp actinic keratoses. Br. J.Dermatol 145: 502-504, 2002.
16. Fabbrocini G, MP Di Costanzo, AM Riccardo, Quarto M., Colasanti A, Roberti G, Monfrecola G. Photodynamic therapy with topical delta-aminolevulinic acid for the treatment of plantar warts. J.Photochem.Photobiol.B:Biol 61: 30-34, 2001.
17. Dijkstra AT, IM Majoie, JW. van Dongen, H. van Weelden, WA van Vloten. Photodynamic therapy with violet light and topical aminolevulinic acid in the treatment of actinic keratosis, Bowens disease and basal cell carcinoma. J.Eur.Acad.Dermatol.Venerol 15: 550-554, 2001.
18. Szeimies RM, S Karrer, S Radakovic-Fijan, Tanew A, Calzavara-Pinton PG, Zane C, Sidoroff A, Hempel M., Ulrich J, Proebstle T, Meffert H, Mulde, Salomon D, Dittmar HC, Bauer JW., Kernland K, Braathen L. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective randomized study. J.Am.Acad.Dermatol 47: 258-262, 2002.
19. Piot B, N Rousset, P Lenz, Eleouet S, Carre J, Vonarx V, Bourre L, Patrice T. Enhancement of delta aminolevulinic acid-photodynamic therapy in vivo by decreasing tumor pH with glucose and amiloride. Laryngoscope 111: 2205-2213, 2001.
20. De Rosa FS, IM Marchetti, JA Thomazini, AC Tedesco, MV Lopes, B Bentley, A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy. J.Control.Rel 65: 359-366, 2000.
21. Casas A, H Fukuda, G Di Venosa, AM Del Battle. The influence of the vehicle on the synthesis of porphyrins after topical application of 5-aminolevulinic acid. Implications in cutaneous photodynamic sensitization. Br.J.Dermatol 143: 564-572, 2000.
22. Peng Q, T Warloe, J Moan, Heyerdahl H, Steen HB, Nesland JM, Giercksky K-E. Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Photochem.Photobiol 62: 906-913, 1995.
23. Malik Z, G Kostenich, L Roitman, B Ehrenberg, A Orenstein. Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumors of mice.J.Photochem.Photobiol.B:Biol 28: 213-218, 1995.